Explore more publications!

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on November 24, 2025

Evoq Technologies Launches Twilight™: A Breakthrough, FDA-Registered Class I Medical Device
Nutraland USA’s Somato® Tomato Fruit Extract Earns Non-GMO Project Verified Status
Zest Clinic Announces Focused Health Services for Men and Women in Singapore
Hernia Repair Devices Market Worth $8.7 Billion by 2032, At a CAGR of 4.3% | Driven by Rising Hernia Burden
Contraceptives Market CAGR to be at 13.2% from 2025 to 2032 | $47.14 Billion Industry Revenue by 2032 | Says CMI
DFMC Reports Rising IVF Success & Normal Delivery Outcomes Under Expert Multi-Specialty Team
NATIONAL SPACE SOCIETY ROTHBLATT SPACE SETTLEMENT BUSINESS PLAN COMPETITION IS OPEN FOR ENTRIES THROUGH FEBRUARY 15 2026
Prefilled Syringes Market Growth Outlook: CAGR of 5.6% and Value Reaching USD 10.51 Billion by 2032 | Braun SE, GSK plc.
CXperks & 22X Ventures Form JV to Advance Behavioral Data Engagement for Healthcare & Experience-Driven Industries
Antibody-Drug Conjugates (ADC) Market Set to Witness Significant Growth by 2025-2032 | Hoffmann-La Roche, AbbVie Inc.
Dental Equipment Market Outlook: Key Sectors Set to Witness Significant Growth by 2025–2032 | 3M, Dentsply Sirona
Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil® Revenue
Poultry Diagnostics Market to Reach $2.1 Billion by 2033 at 10.4% CAGR
cPLA2 Inhibition with Fexofenadine Protects Cartilage in Degenerative Joint Disease
Clinical Decision Support System Market to Hit $14.9 Bn by 2033 at 10.9% CAGR
Addiction Treatment Market to Reach $16.7 Billion by 2033, Growing at 6.6% CAGR
Lipid Nanoparticles Market to Hit $3.1 Billion by 2033, Expanding at 13.1% CAGR
Breast Pumps Market to Hit USD 1,518.4 Million in 2032, Driven by Rising Number of Working Women
Ultragenyx to Participate in Investor Conferences in December
Onco360® Has Been Selected as The National Specialty Pharmacy Partner for HYRNUO® (sevabertinib)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions